These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10475721)

  • 1. A comparison of the effects of olanzapine, haloperidol and placebo on cognitive and psychomotor functions in healthy elderly volunteers.
    Beuzen JN; Taylor N; Wesnes K; Wood A
    J Psychopharmacol; 1999; 13(2):152-8. PubMed ID: 10475721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The acute effects of amisulpride (50 mg and 200 mg) and haloperidol (2 mg) on cognitive function in healthy elderly volunteers.
    Legangneux E; McEwen J; Wesnes KA; Bergougnan L; Miget N; Canal M; L'Heritier C; Pinquier JL; Rosenzweig P
    J Psychopharmacol; 2000 Jun; 14(2):164-71. PubMed ID: 10890311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychomotor and memory effects of haloperidol, olanzapine, and paroxetine in healthy subjects after short-term administration.
    Morrens M; Wezenberg E; Verkes RJ; Hulstijn W; Ruigt GS; Sabbe BG
    J Clin Psychopharmacol; 2007 Feb; 27(1):15-21. PubMed ID: 17224707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Actigraphic measurement of the effects of single-dose haloperidol and olanzapine on spontaneous motor activity in normal subjects.
    Kiang M; Daskalakis ZJ; Christensen BK; Remington G; Kapur S
    J Psychiatry Neurosci; 2003 Jul; 28(4):293-9. PubMed ID: 12921224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychomotor, Cognitive, extrapyramidal, and affective functions of healthy volunteers during treatment with an atypical (amisulpride) and a classic (haloperidol) antipsychotic.
    Ramaekers JG; Louwerens JW; Muntjewerff ND; Milius H; de Bie A; Rosenzweig P; Patat A; O'Hanlon JF
    J Clin Psychopharmacol; 1999 Jun; 19(3):209-21. PubMed ID: 10350027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of risperidone on psychometric and cognitive functions in healthy elderly volunteers.
    Allain H; Tessier C; Bentué-Ferrer D; Tarral A; Le Breton S; Gandon M; Bouhours P
    Psychopharmacology (Berl); 2003 Feb; 165(4):419-29. PubMed ID: 12459926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The differential effects of chlorpromazine and haloperidol on latent inhibition in healthy volunteers.
    McCartan D; Bell R; Green JF; Campbell C; Trimble K; Pickering A; King DJ
    J Psychopharmacol; 2001 Jun; 15(2):96-104. PubMed ID: 11448094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers.
    Otmani S; Demazières A; Staner C; Jacob N; Nir T; Zisapel N; Staner L
    Hum Psychopharmacol; 2008 Dec; 23(8):693-705. PubMed ID: 18763235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosing the antipsychotic medication olanzapine.
    Nemeroff CB
    J Clin Psychiatry; 1997; 58 Suppl 10():45-9. PubMed ID: 9265916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multilead quantitative electroencephalogram profile and cognitive evoked potentials (P300) in healthy subjects after a single dose of olanzapine.
    Hubl D; Kleinlogel H; Frölich L; Weinandi T; Maurer K; Holstein W; Czekalla J; Dierks T
    Psychopharmacology (Berl); 2001 Nov; 158(3):281-8. PubMed ID: 11713618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subjective experience and D2 receptor occupancy in patients with recent-onset schizophrenia treated with low-dose olanzapine or haloperidol: a randomized, double-blind study.
    de Haan L; van Bruggen M; Lavalaye J; Booij J; Dingemans PM; Linszen D
    Am J Psychiatry; 2003 Feb; 160(2):303-9. PubMed ID: 12562577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The acute and long-term effect of olanzapine compared with placebo and haloperidol on serum prolactin concentrations.
    Crawford AM; Beasley CM; Tollefson GD
    Schizophr Res; 1997 Jul; 26(1):41-54. PubMed ID: 9376336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder.
    Bilder RM; Goldman RS; Volavka J; Czobor P; Hoptman M; Sheitman B; Lindenmayer JP; Citrome L; McEvoy J; Kunz M; Chakos M; Cooper TB; Horowitz TL; Lieberman JA
    Am J Psychiatry; 2002 Jun; 159(6):1018-28. PubMed ID: 12042192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a randomized controlled trial.
    Rosenheck R; Perlick D; Bingham S; Liu-Mares W; Collins J; Warren S; Leslie D; Allan E; Campbell EC; Caroff S; Corwin J; Davis L; Douyon R; Dunn L; Evans D; Frecska E; Grabowski J; Graeber D; Herz L; Kwon K; Lawson W; Mena F; Sheikh J; Smelson D; Smith-Gamble V;
    JAMA; 2003 Nov; 290(20):2693-702. PubMed ID: 14645311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative symptoms: a path analytic approach to a double-blind, placebo- and haloperidol-controlled clinical trial with olanzapine.
    Tollefson GD; Sanger TM
    Am J Psychiatry; 1997 Apr; 154(4):466-74. PubMed ID: 9090332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychomotor and cognitive effects of a single oral dose of talnetant (SB223412) in healthy volunteers compared with placebo or haloperidol.
    Liem-Moolenaar M; Gray FA; de Visser SJ; Franson KL; Schoemaker RC; Schmitt JA; Cohen AF; van Gerven JM
    J Psychopharmacol; 2010 Jan; 24(1):73-82. PubMed ID: 18755817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial.
    Beasley CM; Tollefson G; Tran P; Satterlee W; Sanger T; Hamilton S
    Neuropsychopharmacology; 1996 Feb; 14(2):111-23. PubMed ID: 8822534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of chronic haloperidol and olanzapine exposure on brain cholinergic markers and spatial learning in rats.
    Terry AV; Hill WD; Parikh V; Evans DR; Waller JL; Mahadik SP
    Psychopharmacology (Berl); 2002 Dec; 164(4):360-8. PubMed ID: 12457265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol.
    Keefe RS; Seidman LJ; Christensen BK; Hamer RM; Sharma T; Sitskoorn MM; Lewine RR; Yurgelun-Todd DA; Gur RC; Tohen M; Tollefson GD; Sanger TM; Lieberman JA
    Am J Psychiatry; 2004 Jun; 161(6):985-95. PubMed ID: 15169686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia.
    Wright P; Birkett M; David SR; Meehan K; Ferchland I; Alaka KJ; Saunders JC; Krueger J; Bradley P; San L; Bernardo M; Reinstein M; Breier A
    Am J Psychiatry; 2001 Jul; 158(7):1149-51. PubMed ID: 11431240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.